“…NCAM2 has two different isoforms: NCAM2.1, with a cytoplasmatic domain, and NCAM2.2, which is GPI-anchored (Von Campenhausen et al 1997; Alenius and Bohm 2003). In the central nervous system (CNS), the functions of NCAM2 have been mainly linked to the regulation of the formation and maintenance of axonal and dendritic biology compartments in the olfactory system (Alenius & Bohm, 2003; Kulahin & Walmod, 2010; Parcerisas, Ortega-Gascó, Pujadas, et al, 2021; Winther et al, 2012), and to the control of neural polarization, neurite outgrowth, dendrite development, and synapse formation and maintenance in the cortex and hippocampus through a complex panel of interactors (Leshchyns’Ka et al, 2015; Parcerisas et al, 2020; Sheng et al, 2015; Parcerisas, Ortega-gascó, et al, 2021). Interestingly, NCAM2 has been associated with different pathologies including Down syndrome, autism, and Alzheimer’s disease (JP et al, 2011; Leshchyns’Ka et al, 2015; Paoloni-Giacobino et al, 1997; Parr et al, 2006; Scholz et al, 2016; Winther et al, 2012).…”